PACLITAXEL for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 47 adverse event reports in the FDA FAERS database where PACLITAXEL was used for Prostate cancer.
Most Reported Side Effects for PACLITAXEL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 4,553 | 5.9% | 572 | 1,391 |
| Nausea | 4,521 | 5.9% | 488 | 2,147 |
| Dyspnoea | 4,519 | 5.8% | 453 | 2,052 |
| Diarrhoea | 4,289 | 5.6% | 591 | 2,513 |
| Off label use | 4,075 | 5.3% | 595 | 1,415 |
| Anaemia | 3,949 | 5.1% | 599 | 1,918 |
| Neuropathy peripheral | 3,508 | 4.5% | 404 | 788 |
| Malignant neoplasm progression | 3,484 | 4.5% | 916 | 760 |
| Fatigue | 3,418 | 4.4% | 500 | 1,568 |
| Death | 3,143 | 4.1% | 3,137 | 378 |
| Pyrexia | 3,083 | 4.0% | 352 | 2,331 |
| Vomiting | 3,049 | 3.9% | 371 | 1,785 |
| Disease progression | 2,939 | 3.8% | 801 | 554 |
| Febrile neutropenia | 2,938 | 3.8% | 569 | 1,915 |
| Thrombocytopenia | 2,580 | 3.3% | 424 | 939 |
Other Indications for PACLITAXEL
Breast cancer (10,215)
Product used for unknown indication (6,156)
Ovarian cancer (4,631)
Non-small cell lung cancer (4,609)
Triple negative breast cancer (3,863)
Pancreatic carcinoma (3,386)
Breast cancer metastatic (3,241)
Pancreatic carcinoma metastatic (2,712)
Lung neoplasm malignant (1,747)
Chemotherapy (1,425)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)